Last reviewed · How we verify
NCT05566704
Retrospective Modulus ALIF Study
trial testing Modulus ALIF System in Degenerative Disc Disease in 123 participants. Completed in 1 May 2024.
15 October 2022
Quick facts
| Lead sponsor | NuVasive |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 123 |
| Start date | 18 August 2022 |
| Primary completion | 15 October 2022 |
| Estimated completion | 1 May 2024 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Modulus ALIF System
Conditions studied
- Degenerative Disc Disease — all drugs for Degenerative Disc Disease →
- Spondylolisthesis — all drugs for Spondylolisthesis →
- Stenosis — all drugs for Stenosis →
Sponsor
NuVasive — full company profile →
Who can join
18 and older, any sex, with Degenerative Disc Disease or Spondylolisthesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05566704
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Degenerative Disc Disease
Currently open trials in the same condition.
- NCT07254806 — A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to · Phase 3 · recruiting
- NCT04679844 — Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Au · NA · recruiting
- NCT06704919 — Conduit Cages and Fibergraft BG Putty · recruiting
- NCT06053242 — Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Ba · Phase 1, PHASE2 · recruiting
- NCT03810573 — Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis · NA · recruiting
Other NuVasive trials
Trials by the same sponsor.
- NCT06741514 — A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures · enrolling by invitation
- NCT05691231 — Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels · enrolling by invitation
- NCT05066711 — NuVasive® ACP System Study · enrolling by invitation
- NCT04980378 — Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc · completed
- NCT04689880 — XLIF Decade Plate System Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05566704 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NuVasive
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05566704.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing